UM

Browse/Search Results:  1-10 of 22 Help

Selected(0)Clear Items/Page:    Sort:
3,3′,4,5′-Tetramethoxy-trans-stilbene and 3,4′,5-trimethoxy-trans-stilbene prevent oxygen-glucose deprivation-induced injury in brain endothelial cell Journal article
Zhou, Chunxiu, Zhou, Yan, Vong, Chi Teng, Khan, Haroon, Cheang, Wai San. 3,3′,4,5′-Tetramethoxy-trans-stilbene and 3,4′,5-trimethoxy-trans-stilbene prevent oxygen-glucose deprivation-induced injury in brain endothelial cell[J]. Journal of Cellular and Molecular Medicine, 2024, 28(16), e70008.
Authors:  Zhou, Chunxiu;  Zhou, Yan;  Vong, Chi Teng;  Khan, Haroon;  Cheang, Wai San
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:4.3/5.0 | Submit date:2024/08/19
Blood–brain Barrier  Ischemic Stroke  Oxygen–glucose Deprivation  Resveratrol Derivative  Tight Junction Proteins  
Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects Journal article
Shahcheraghi,Seyed Hossein, Salemi,Fateme, Small,Shlomo, Syed,Suliman, Salari,Farzam, Alam,Waqas, Cheang,Wai San, Saso,Luciano, Khan,Haroon. Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects[J]. Phytotherapy Research, 2023, 37(4), 1590-1605.
Authors:  Shahcheraghi,Seyed Hossein;  Salemi,Fateme;  Small,Shlomo;  Syed,Suliman;  Salari,Farzam; et al.
Favorite | TC[WOS]:40 TC[Scopus]:41  IF:6.1/7.0 | Submit date:2023/08/03
Biotechnological Prospects  Nrf2  Oxidative Stress  Resveratrol  Therapeutic Status  
Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects Journal article
Shahcheraghi, SH, Salemi, F, Small, S, Syed, S, Salari, F, Alam W, Cheang, Wai San, Saso, L, Khan, H. Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects[J]. Phytotherapy Research, 2023, 37(4), 1590-1605.
Authors:  Shahcheraghi, SH;  Salemi, F;  Small, S;  Syed, S;  Salari, F; et al.
Favorite | TC[WOS]:40 TC[Scopus]:41  IF:6.1/7.0 | Submit date:2022/08/11
Biotechnological Prospects  Nrf2  Oxidative Stress  Resveratrol  Therapeutic Status  
Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol Journal article
Bai, Long Bo, Yau, Lee Fong, Tong, Tian Tian, Chan, Wai Him, Zhang, Wei, Jiang, Zhi Hong. Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol[J]. Pharmacology Research and Perspectives, 2022, 10(4).
Authors:  Bai, Long Bo;  Yau, Lee Fong;  Tong, Tian Tian;  Chan, Wai Him;  Zhang, Wei; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.9/2.9 | Submit date:2023/01/30
Combination Therapy  Ginsenosides  Lc-mrm  Nad++  Nmn  Resveratrol  
Peonidin-3-O-glucoside and cyanidin increase osteoblast differentiation and reduce RANKL-induced bone resorption in transgenic medaka Journal article
Zhitao Ren, Nishikant A. Raut, Temitope O. Lawal, Shital R. Patel, Simon M. Lee, Gail B. Mahady. Peonidin-3-O-glucoside and cyanidin increase osteoblast differentiation and reduce RANKL-induced bone resorption in transgenic medaka[J]. Phytotherapy Research, 2021, 35(11), 6255-6269.
Authors:  Zhitao Ren;  Nishikant A. Raut;  Temitope O. Lawal;  Shital R. Patel;  Simon M. Lee; et al.
Favorite | TC[WOS]:20 TC[Scopus]:20  IF:6.1/7.0 | Submit date:2021/12/08
Apoptosis  Cyanidin  Osteoblasts  Osteoclast  Osteoporosis  P53  Peonidin  Rankl  Resveratrol  Sirt1  
Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies Review article
2021
Authors:  Su, Cheng Fu;  Jiang, Li;  Zhang, Xiao Wen;  Iyaswamy, Ashok;  Li, Min
Favorite | TC[WOS]:46 TC[Scopus]:49  IF:4.4/5.0 | Submit date:2021/12/07
Meta-analysis  Neuroprotective Effects  Parkinson’s Disease  Pd Animal Models  Resveratrol  
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation Journal article
Xiong, Sha, Liu, Wei, Zhou, Yile, Mo, Yousheng, Liu, Yao, Chen, Xiaojia, Pan, Huafeng, Yuan, Dongsheng, Wang, Qi, Chen, Tongkai. Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation[J]. Asian Journal of Pharmaceutical Sciences, 2020, 15(4), 518-528.
Authors:  Xiong, Sha;  Liu, Wei;  Zhou, Yile;  Mo, Yousheng;  Liu, Yao; et al.
Favorite | TC[WOS]:47 TC[Scopus]:50  IF:10.7/9.0 | Submit date:2021/03/02
Anti-parkinsonian Efficacy  Brain Permeability  Nanocrystals  Oral Absorption  Resveratrol  
Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies Journal article
Chen,Jia Yue, Zhu,Qi, Zhang,Shuang, OuYang,Defang, Lu,Jia Hong. Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies[J]. Pharmacological Research, 2019, 150, 104476.
Authors:  Chen,Jia Yue;  Zhu,Qi;  Zhang,Shuang;  OuYang,Defang;  Lu,Jia Hong
Favorite | TC[WOS]:39 TC[Scopus]:47  IF:9.1/9.0 | Submit date:2021/03/02
Alzheimer's Disease  Animal Ad Models  Neuroprotective Effects  Resveratrol  
Targeted Brain Delivery of Resveratrol Using Graphene Oxide Conjugated Lactoferrin for Parkinson's Disease Therapy Conference paper
Xiong, Sha, Liu, Yao, Chen, Xiaojia, Zhang, Han, Chen, Tongkai. Targeted Brain Delivery of Resveratrol Using Graphene Oxide Conjugated Lactoferrin for Parkinson's Disease Therapy[C], Hong Kong:The 9th International Multidisciplinary Conference on Optofluidics (IMCO 2019), 2019.
Authors:  Xiong, Sha;  Liu, Yao;  Chen, Xiaojia;  Zhang, Han;  Chen, Tongkai
Favorite |  | Submit date:2022/08/02
Resveratrol  Parkinson's Disease  Blood-brain Barrier  Graphene Oxide  Lactoferrin  
Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship Journal article
Liu, Minzhuo, Tang, Fen, Liu, Qi, Xiao, Jianbo, Cao, Hui, Chen, Xiaoqing. Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship[J]. Natural Product Research, 2018, 34(17), 2490-2494.
Authors:  Liu, Minzhuo;  Tang, Fen;  Liu, Qi;  Xiao, Jianbo;  Cao, Hui; et al.
Favorite | TC[WOS]:18 TC[Scopus]:16  IF:1.9/2.1 | Submit date:2021/12/06
Advanced Glycation Endproducts  Antiglycation Mechanism  Resveratrol Glucosides  Structure-activity Relationship